Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns
Melanoma Survivors: Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns
1 other identifier
observational
160
1 country
1
Brief Summary
The purpose of this study is to examine the health behaviors of melanoma survivors. We want to know about their thoughts and concerns. Melanoma is a type of skin cancer. The number of people being diagnosed with melanoma is growing. Many people who are diagnosed with melanoma are young. Little research has been done to find out how melanoma survivors feel years after they have been treated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2006
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2006
CompletedFirst Submitted
Initial submission to the registry
August 15, 2007
CompletedFirst Posted
Study publicly available on registry
August 17, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2015
CompletedJuly 16, 2015
July 1, 2015
8.8 years
August 15, 2007
July 15, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
This pilot study will provide baseline data to enhance our understanding of the behaviors of melanoma survivors.
2 hours
Secondary Outcomes (1)
Conduct a pilot survey study of melanoma survivors to describe the behavioral and psychosocial issues in melanoma survivors. Results from the survey will enable us to obtain preliminary data in order to conduct a larger scale study.
half an hour
Study Arms (2)
Specific Aim 1- Focus Group
Conduct focus groups in melanoma survivors to enhance the understanding of the behavioral aspects of: * Screening, skin self-examination, sun protection, and other cancer preventive practices; * Cognitive factors (knowledge, awareness, melanoma worry, and perceived risk) related to screening and sun protection practices; and, * Impact of melanoma on quality of life, family relationships, and economic issues arising from treatment
Specific Aim 2- Survey Study
A separate random sample of melanoma survivors will complete the pilot questionnaire. To enhance completion rates, survey instruments will be developed to be both self-administered and interviewer-administered. The survey will include questions from existing surveys, regarding demographics, sun sensitivity, eye and hair color, color of untanned skin, sun exposure, skin selfexamination, sun protection practices and frequency of sunburns, psychosocial/cognitive factors: skin cancer knowledge, skin awareness, cancer worry, perceived risk of recurrence, cancer risk and screening behaviors, and access to health care and insurance.
Interventions
Conduct focus groups in melanoma survivors to enhance the understanding of the behavioral aspects of: * Screening, skin self-examination, sun protection, and other cancer preventive practices; * Cognitive factors (knowledge, awareness, melanoma worry, and perceived risk) related to screening and sun protection practices; and, * Impact of melanoma on quality of life, family relationships, and economic issues arising from treatment
History of sun exposure Medical factors Affect, cognition, and quality of life Behavioral adoption Demographics Phenotypic factors Economic/healthcare factors
Eligibility Criteria
Eligible melanoma survivors will be initially identified and screened using the Melanoma DMT Database. We will select a random sample from the database.
You may qualify if:
- For the focus group recruitment (Specific Aim 1) - Patients with melanoma (invasive primary cutaneous melanoma, stages 1-III), who have been treated at MSKCC from 1996-2005
- For the survey group recruitment (Specific Aim 2):
- patients with melanoma (invasive primary cutaneous melanoma, stages 1-III), who have been treated at MSKCC from 2001-2011• Ability to sign informed consent which indicates the psychosocial, behavioral, epidemiological nature of this study
- Age ≥ or = to 18 years and fluent in the English language
You may not qualify if:
- Patients with intraepithelial (in situ) melanoma
- Patients with stage IV melanoma
- Patients with nodal or visceral melanoma without a documented primary lesion
- Patients with prior malignancies For the focus group recruitment (Specific Aim 1): (patients treated at MSKCC from 1996-2005) who have a diagnosis \>10 years ago from treatment. For the survey group recruitment (Specific Aim 2): patients treated at MSKCC from 2001-2011)who have a diagnosis \>10 years ago from treatment.
- Patients with a recent diagnosis of melanoma, \<12 months
- Patients who are one year or more post diagnosis and are still receiving treatment for their melanoma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Memorial Sloan-Kettering Cancer Center 1275 York Avenue
New York, New York, 10065, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susan Oliveria, ScD, MPH
Memorial Sloan Kettering Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 15, 2007
First Posted
August 17, 2007
Study Start
October 1, 2006
Primary Completion
July 1, 2015
Study Completion
July 1, 2015
Last Updated
July 16, 2015
Record last verified: 2015-07